SUBLIMAZE

This brand name is authorized in Ireland, New Zealand, United Kingdom, South Africa

Active ingredients

The drug SUBLIMAZE contains one active pharmaceutical ingredient (API):

1 Fentanyl UNII MUN5LYG46H - FENTANYL CITRATE

Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects. Read about Fentanyl

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUBLIMAZE Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01AH01	Fentanyl	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 45227
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1268
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/2.9/1014, Q/2.9/0034